Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Perindopril Tert-butylamine After Meal
NCT04556110Phase 1Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Nov 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of perindopril in hypertension (HTN) (2 arms), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd. Primary endpoints: Maximum Plasma Concentration of Perindopril and Area Under the Plasma Concentration Curve of Perindopril. Started Nov 2018; status: completed.
02
Drugs
perindopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04556110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04556110.